A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas
DURAN, I, KORTMANSKY, J, BIRLE, D, POND, G. R, ARBOINE, D, DANCEY, J, AVIEL-RONEN, S, TSAO, M.-S, HEDLEY, D, SIU, L. L, SINGH, D, HIRTE, H, KOCHA, W, GOSS, G, LE, L, OZA, A, NICKLEE, T, HO, J
Published in British journal of cancer (06.11.2006)
Published in British journal of cancer (06.11.2006)
Get full text
Journal Article
Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors
Markman, B., Tabernero, J., Krop, I., Shapiro, G.I., Siu, L., Chen, L.C., Mita, M., Melendez Cuero, M., Stutvoet, S., Birle, D., Anak, Ö., Hackl, W., Baselga, J.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
The influence of diet therapeutic intervention on the sarcopenic index of patients with metabolic syndrome
Ghitea, T C, Vlad, S, Birle, D, Tit, D M, Lazar, L, Nistor-Cseppento, C, Behl, T, Bungau, S
Published in Acta endocrinologica (Bucharest, Romania : 2005) (01.10.2020)
Published in Acta endocrinologica (Bucharest, Romania : 2005) (01.10.2020)
Get full text
Journal Article
Protein tyrosine phosphatases
Mustelin, T, Feng, G S, Bottini, N, Alonso, A, Kholod, N, Birle, D, Merlo, J, Huynh, H
Published in Frontiers in bioscience (01.01.2002)
Published in Frontiers in bioscience (01.01.2002)
Get full text
Journal Article
A Phase II Trial with Pharmacodynamic Endpoints of the Proteasome Inhibitor Bortezomib in Patients with Metastatic Colorectal Cancer
MACKAY, Helen, HEDLEY, David, WRIGHT, John, SIU, Lillian, MOORE, Malcolm, OZA, Amit, MAJOR, Pierre, TOWNSLEY, Carol, MACKENZIE, Mary, VINCENT, Mark, DEGENDORFER, Pam, TSAO, Ming-Sound, NICKLEE, Trudey, BIRLE, Diana
Published in Clinical cancer research (01.08.2005)
Published in Clinical cancer research (01.08.2005)
Get full text
Journal Article
Carbonic Anhydrase IX Expression, Hypoxia, and Prognosis in Patients with Uterine Cervical Carcinomas
HEDLEY, David, PINTILIE, Melania, WOO, Jennifer, MORRISON, Andrew, BIRLE, Diana, FYLES, Anthony, MILOSEVIC, Michael, HILL, Richard
Published in Clinical cancer research (15.11.2003)
Get full text
Published in Clinical cancer research (15.11.2003)
Journal Article
A first-in-human phase I study of BKM120, an oral pan-class I PI3K inhibitor, in patients (pts) with advanced solid tumors
Baselga, J., De Jonge, M. J., Rodon, J., Burris, H. A., Birle, D. C., De Buck, S. S., Demanse, D., Ru, Q. C., Goldbrunner, M., Bendell, J. C.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Negative Feedback Regulation of the Tumor Suppressor PTEN by Phosphoinositide-Induced Serine Phosphorylation
Birle, Diana, Bottini, Nunzio, Williams, Scott, Huynh, Huong, deBelle, Ian, Adamson, Eileen, Mustelin, Tomas
Published in The Journal of immunology (1950) (01.07.2002)
Published in The Journal of immunology (1950) (01.07.2002)
Get full text
Journal Article
Up-Regulation of the Redox Mediators Thioredoxin and Apurinic/Apyrimidinic Excision (APE)/Ref-1 in Hypoxic Microregions of Invasive Cervical Carcinomas, Mapped Using Multispectral, Wide-Field Fluorescence Image Analysis
Hedley, David, Pintilie, Melania, Woo, Jennifer, Nicklee, Trudey, Morrison, Andrew, Birle, Diana, Fyles, Anthony, Milosevic, Michael, Hill, Richard
Published in The American journal of pathology (01.02.2004)
Published in The American journal of pathology (01.02.2004)
Get full text
Journal Article
Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors
Markman, B, Tabernero, J, Krop, I, Shapiro, G I, Siu, L, Chen, L C, Mita, M, Melendez Cuero, M, Stutvoet, S, Birle, D, Anak, Ö, Hackl, W, Baselga, J
Published in Annals of oncology (01.09.2012)
Get full text
Published in Annals of oncology (01.09.2012)
Journal Article